LUNG TRANSPLANT; COMPLICATIONS
Clinical trials for LUNG TRANSPLANT; COMPLICATIONS explained in plain language.
Never miss a new study
Get alerted when new LUNG TRANSPLANT; COMPLICATIONS trials appear
Sign up with your email to follow new studies for LUNG TRANSPLANT; COMPLICATIONS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Inhaled drug shows promise for lung transplant patients with chronic rejection
Disease control CompletedThis study tested an inhaled form of cyclosporine A (a drug that suppresses the immune system) added to standard care for people who had a single lung transplant and developed chronic lung rejection. The goal was to see if the drug could improve lung function over 48 weeks. The t…
Matched conditions: LUNG TRANSPLANT; COMPLICATIONS
Phase: PHASE3 • Sponsor: Zambon SpA • Aim: Disease control
Last updated May 17, 2026 12:56 UTC
-
Inhaled drug shows promise for lung transplant rejection in phase 3 trial
Disease control CompletedThis study tested whether adding an inhaled form of cyclosporine A (L-CsA) to standard treatment helps people who have chronic lung rejection after a double lung transplant. The trial included 169 adults who had their transplant at least a year earlier. The main goal was to see i…
Matched conditions: LUNG TRANSPLANT; COMPLICATIONS
Phase: PHASE3 • Sponsor: Zambon SpA • Aim: Disease control
Last updated May 17, 2026 12:53 UTC
-
App may cut hospital trips for lung transplant patients
Disease control CompletedThis study tested whether lung transplant patients could use a smartphone app and a home breathing test to replace some routine hospital check-ups. 76 patients were split into two groups: one received standard care, the other used the app to track symptoms and lung function at ho…
Matched conditions: LUNG TRANSPLANT; COMPLICATIONS
Phase: NA • Sponsor: University of Manchester • Aim: Disease control
Last updated Apr 24, 2026 16:17 UTC